Tower Research Capital LLC (TRC) - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$635,072
+90.4%
5,239
+79.8%
0.02%
+81.8%
Q2 2023$333,597
+52270.0%
2,913
-37.0%
0.01%
-45.0%
Q1 2023$637
+69.4%
4,623
+59.5%
0.02%
+25.0%
Q4 2022$376
-99.4%
2,899
+397.3%
0.02%
+1500.0%
Q3 2022$65,000
-94.6%
583
-96.4%
0.00%
-96.3%
Q2 2022$1,199,000
+23.2%
15,986
+28.4%
0.03%
+200.0%
Q1 2022$973,000
+70.4%
12,455
+96.5%
0.01%
-10.0%
Q4 2021$571,000
+202.1%
6,339
+210.4%
0.01%
+100.0%
Q3 2021$189,000
-50.9%
2,042
-58.8%
0.01%
-50.0%
Q2 2021$385,000
+442.3%
4,951
+419.5%
0.01%
+900.0%
Q1 2021$71,000
-89.8%
953
-76.6%
0.00%
-95.2%
Q4 2020$694,000
-4.4%
4,070
-21.3%
0.02%
+162.5%
Q3 2020$726,000
+1016.9%
5,169
+1176.3%
0.01%
+166.7%
Q2 2020$65,000
-48.0%
405
-58.2%
0.00%
-70.0%
Q4 2019$125,000
+166.0%
970
+55.2%
0.01%
+233.3%
Q3 2019$47,000
+4600.0%
625
+8828.6%
0.00%
Q1 2019$1,000
-96.2%
7
-97.0%
0.00%
-100.0%
Q4 2018$26,000
-29.7%
237
+3.0%
0.00%
-33.3%
Q3 2018$37,000
+1133.3%
230
+277.0%
0.00%
Q4 2017$3,000
+50.0%
61
+38.6%
0.00%
Q3 2017$2,000
-98.5%
44
-99.1%
0.00%
-100.0%
Q4 2016$132,000
+76.0%
4,811
+293.1%
0.01%
+100.0%
Q3 2016$75,000
+257.1%
1,224
+9.6%
0.01%
+250.0%
Q2 2016$21,0001,1170.00%
Q1 2016$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2015$14,000
-82.7%
353
-85.9%
0.00%
-75.0%
Q3 2015$81,000
+326.3%
2,498
+298.4%
0.01%
+300.0%
Q2 2015$19,000
-82.2%
627
-92.2%
0.00%
-84.6%
Q1 2015$107,000
+1428.6%
8,045
+1633.8%
0.01%
+1200.0%
Q4 2014$7,000
+250.0%
464
+293.2%
0.00%
Q4 2013$2,000
-97.0%
118
-91.5%
0.00%
-100.0%
Q3 2013$66,000
-25.8%
1,390
-40.6%
0.01%0.0%
Q2 2013$89,0002,3410.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders